8. BERT was thoroughly tested emphasizing it's broad scope (tested on large-scale data integration tasks with up to 5000 datasets from simulated and experimental data of different quantification techniques and omic types (proteomics, transcriptomics, metabolomics) as well as other datatypes)
02.08.2025 15:56 β π 0 π 0 π¬ 0 π 0
6. BERT is super fast (leverages multi-core and distributed-memory systems for up to 11 Γ runtime improvement)
7. BERT is available on Bioconductor
02.08.2025 15:56 β π 0 π 0 π¬ 1 π 0
3. BERT retains data in incomplete datasets upon integration
4. BERT can integrate datasets with different compositions and conditions (integration of unbalanced datasets using covariates)
5. BERT can integrate datasets with unknown conditions (using references)
02.08.2025 15:56 β π 0 π 0 π¬ 1 π 0
BERTs features:
1. BERT can integrate molecular data (Omic data) or other data types (e.g. clinical annotations)
2. BERT tolerates missing data of different types in datasets (e.g. missing at random, missing not at random)
02.08.2025 15:56 β π 0 π 0 π¬ 1 π 0
Including TE transcription profiles into the molecular characterization of ATRTs might reveal new tumor vulnerabilities leading to novel therapeutic interventions, such as immunotherapy.
23.07.2025 19:58 β π 0 π 0 π¬ 0 π 0
--> Differentially transcribed TEs in primary samples are partly reflected in established ATRT-SHH and -MYC cell line models.
23.07.2025 19:58 β π 0 π 0 π¬ 1 π 0
--> ATRT-MYC showed broadly reduced transcript levels of LINE1 and ERVL-MaLR subfamilies and displayed significantly less LTR and LINE1 loci with bidirectional promoter activity.
23.07.2025 19:58 β π 0 π 0 π¬ 1 π 0
--> We investigate the transcriptional profiles of 1.9M LINE1 and LTR elements that differ across ATRT subtypes in primary human samples.
23.07.2025 19:58 β π 0 π 0 π¬ 1 π 0
Atypical teratoid rhabdoid tumors (ATRTs) are very aggressive CNS tumors mainly affecting infants.
Transcriptional activity of transposable elements (TEs), like LINE1s and LTRs, is tightly linked with human cancers as a direct consequence of lifting epigenetic repression over TEs.
23.07.2025 19:58 β π 0 π 0 π¬ 1 π 0
Many thanks to the @dfg.de for funding this research within the #emmynoether programme!
22.07.2025 21:04 β π 0 π 0 π¬ 0 π 0
We provide molecular insights into these rare and severe brain diseases and reveal novel implications of the oncogenic factor LIN28A in extracellular matrix integrity
22.07.2025 21:04 β π 0 π 0 π¬ 1 π 0
Alterations of brain layer morphology in these models were mapped to spatial proteome patterns that were acquired with the Nanosecond-infrared laser system
22.07.2025 21:04 β π 0 π 0 π¬ 1 π 0
β’
In contrast sole stabilisation of CTNNB1 resulted in a distinct developmental brain phenotype similar to Lissencephaly Type 1.
22.07.2025 21:04 β π 1 π 0 π¬ 1 π 0
In a nutshell:
β’
Co-activation of LIN28A and stabilised CTNNB1 in vivo led to pial disruption and neuronal overmigration resembling a servere human developmental disorder of the brain which is called the Cobblestone Lissencephaly Type 2.
22.07.2025 21:04 β π 0 π 0 π¬ 1 π 0
Jelenas work on #spatialproteomics of the developing brain has now been published in Molecular md Cellular Proteomics (www.mcponline.org/article/S153... )
#neurooncology #neurodevelopment #proteomics #Neuropathology #zmnh #ukeHamburg
22.07.2025 21:04 β π 1 π 1 π¬ 1 π 0
Finally, hypomethylation at the FGFR3 locus, together with increased FGFR3 protein expression, was observed in 97% of cases, highlighting FGFR3 as a potential future treatment target.
13.06.2025 21:08 β π 0 π 0 π¬ 0 π 0
DNA methylation profiles were rather homogenous but global DNA hypomethylation was a feature of tumors associated with higher recurrence risk.
13.06.2025 21:08 β π 0 π 0 π¬ 1 π 0
Of note, classic histopathological criteria such as atypia and the cell proliferation index were not reproducible across neuropathologists.
Instead, patient age and treatment strategy were key factors associated with survival outcomes in the cohort.
13.06.2025 21:08 β π 0 π 0 π¬ 1 π 0
Antonia Gocke representing our group at #SNOPeds2025 !
She shows our data on LIN28A in atypical teratoid rhabdoid tumors and proteome data on a large cohort of #ependymoma. Fantastic job Antonia!
#atrt #braintumor #pediatriccancer #kinderkrebs #proteomics #neurooncology #Neuropathology #zmnh
17.05.2025 19:54 β π 3 π 0 π¬ 0 π 0
The developing brain cortex is a complex structure relying on a specific spatiotemporal orchestration of signalling molecules and pathways.
To grasp this complexity Jelena Navolic established spatial proteome analyses of the brain applying Nanosecond Infrared Laser Ablation (NIRL).
27.02.2025 19:32 β π 0 π 0 π¬ 1 π 0
Dear Jelena, now you successfully defended your PhD β congratulations! We are very happy to have you in the team!
#proteomics #etmr #spatialproteomics #zmnh #ukeHamburg #neurooncology #neurodevelopment #neuropathology
27.02.2025 19:32 β π 4 π 0 π¬ 1 π 0
Conversely, methods such as KNNImpute/LLSImpute might be biased to compute their estimates from features (e.g. proteins) with lower average variance - yet, we personally made good experiences with KNN-imputed MS-proteomics data in the past.
13.02.2025 18:27 β π 0 π 0 π¬ 1 π 0
Contemporary methods uncertainty-quantification might be an interesting approach here, in addition to methods such as MICE.
13.02.2025 18:27 β π 1 π 0 π¬ 1 π 0
Given suitable amounts of training data and sufficient regularization, we would expect NN-based (single-imputation) estimates to converge approximately to the first moments of the distribution without reflecting the heteroskedasticity (cf. bias-variance trade-off).
13.02.2025 18:27 β π 0 π 0 π¬ 1 π 0
To the best of our knowledge, the impact of heteroskedasticity has not been thoroughly characterized on quantitative data for the majority of Neighbor/Regression-based and NN-based imputation methods.
13.02.2025 18:26 β π 1 π 0 π¬ 1 π 0
Postdoc in LehtiΓΆ group at SciLifeLabs/Karalinsa. Canadian abroad π¨π¦. Proteomics and PTMs.
Our mission is to enable the promise of genomics to better human health by creating the worldβs most advanced sequencing technologies.
Das deutschsprachige @RealScientists.
Echte Wissenschaft von echten ForscherInnen, AutorInnen, KommunikatorInnen, KΓΌnstlerInnen... Diese Woche: Pause
Training computers to understand genes so I donβt have to. Big data, small p-values, and a stubborn belief that biology makes sense. Data science & ML for functional genomics.
Institute of Human Genetics, Bonn, Germany @Billmann Lab
previously @FZJ INM7
Clinician scientist @ukehamburg @inims_hamburg, interested in #MS π§ with a focus on #Tcells, #sexdifferences and #pregnancy effects
Neurobiologist. Interested in tumor innervation.#CancerNeuroscience #PNS #tumormicroenvironment, #innervation #PDAC.
We are the Stengel Lab at the University of Constance (@uni-konstanz.de) developing novel MS-based approaches to investigate proteome organization and cellular compartmentalization. Learn more about our work: https://www.biologie.uni-konstanz.de/stengel/
Head of the Tumor Microenvironment Laboratory at Institut Curie. #CancerResearch, #Neuro-oncology, #BrainTumor, #GBM, #Glioblastoma, #ResistanceMechanism, #TumorMicroenrironment, #TME, #Mechanobiology, #CellPlasticity
https://institut-curie.org/team/seano
Scientist, cancer researcher, studying brain & lung tumors and synthetic genetics, occasionally cooking and supporting Inter FC
Established by Alexβs Lemonade Stand Foundation (ALSF) to empower pediatric cancer experts poised for the next big discovery with the knowledge, data, and tools to reach it.
Neuroscientist passionate about Glia and Neuroimmunology & immune-brain cross talk in health & disease.
Foodie & Wine enthusiast. #openscience and collaboration
Confidently take your research to new depths with MERSCOPE Ultra integrating single-cell and spatial multiomics analysis powered by MERFISH technology.
Clinician Scientist I Neuropathology @ University Clinic of Freiburg | Hem/Onc - Neuroimmunology - Precision medicine | EANO Youngster Committee
Neuroscientist. Neuro-Oncologist. Mom.
Official account of the Friedrich-Alexander-University Erlangen-NΓΌrnberg (FAU). We are Moving Knowledge.
fau.de
Impressum: https://www.fau.de/impressum/
Datenschutz: https://www.fau.de/datenschutz/
Enthusiastic brain barriers researcher located in Switzerland involved in many exciting international collaborations
Non-profit publisher of @embojournal.org, @emboreports.org, @embomolmed.org, @molsystbiol.org and @lsajournal.org. #OpenScience #Policy
Welcome to The Lancet, one of the worldβs leading medical journals, published weekly since 1823.
π thelancet.com